Of all the medical diagnoses a physician can make, the diagnosis of ALS--amyotrophic lateral sclerosis--is one of the most devastating. Commonly known as Lou Gehrig's disease, medical researchers are hard at work seeking a cure or at least a way to ease the symptoms of this neurological disease.
The University of Michigan is in the forefront of this research. Researchers are asking the question, can stem cell injections delivered directly into the spine lessen the effects of ALS?
Researchers at the U of M hospital have recently wrapped up phase 1 of a critical trial exploring just how these stem cell injections work in patients with the deadly disease, and they have gotten the go-ahead to proceed with phase 2.
The head researcher of this ALS project, Dr. Eva Feldman joined us today.
Listen to the full interview above.
